Guaifenesin And Pseudoephedrine Hcl Tablet, Extended Release
Product Images NDC 58602-834

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Guaifenesin And Pseudoephedrine Hcl (NDC 58602-834). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurohealth Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (600 mg/60 mg (18 Tablet Carton Label))

Packaging label for Guaifenesin and Pseudoephedrine Hydrochloride Extended-Release Tablets 1200 mg/120 mg by Aurohealth LLC. The label highlights it as a maximum strength expectorant and nasal decongestant with 12-hour symptom relief, including clearing nasal/sinus congestion and loosening mucus. The package contains 12 extended-release tablets. The label includes drug facts, usage warnings, manufacturer information, tamper-evident instructions, and NDC 58602-834.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.